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Intraperitoneal administration of concanavalin A (ConA, 25 mg/kg b.w.), 
a cell-binding plant lectin was used for inducing infl ammatory ascites, and poten-
tial inhibitors were tested in 1 h and 2.5 h experiments, i.e. still before the major 
infl ux of leucocytes. At the end of the experiment the peritoneal fl uid was collected 
and measured.
The ConA-induced ascites was signifi cantly (p<0.01) and dose-dependently 
inhibited by icatibant (HOE-140), a synthetic polypeptide antagonist of bradykinin 
receptors. Aprotinin, a kallikrein inhibitor protein also had signifi cant (p<0.01), but 
less marked inhibitory effect. L-NAME, an inhibitor of NO synthesis, and atropine 
methylnitrate, an anticholinergic compound, were ineffective.
It is concluded, that the kallikrein/kinin system contributes to the mediation 
of the ConA-induced ascites by increasing subperitoneal vascular permeability, in-
dependent of the eventual vasodilation produced by NO. It is known, that membrane 
glycoproteins are aggregated by the tetravalent ConA and the resulting distortion of 
membrane structure may explain the activation of the labile prekallikrein.
Complete inhibition of the ConA-induced ascites could not be achieved by 
aprotinin or icatibant, which indicates the involvement of additional mediators.
Keywords: ascites, concanavalin, kallikrein, bradykinin, aprotinin, icati-
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Introduction
The peritoneal fl uid originates mainly from the subperitoneal vessels of the 
intestines and provides lubrication for the movement of abdominal organs. The 
excess fl uid is returned to the lymphatics through the lymphatic stomata [1], lo-
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cated mainly at the diaphragm. Introduced substances may be absorbed also 
across the mesothelial lining.
The large molecules, due to their slow peritoneal absorption, are more suit-
able for the study of ascites induction, than the small ones. In an earlier study [2] 
a screening of inducer macromolecules was performed. Three groups of com-
pounds were effective, namely the cell-surface binding lectines, the polykations 
(polyLys, polyArg and polyethyleneimine) and a heterogeneous group of polysac-
charides, e.g. the well-known infl ammatory agents zymosan and carrageenan.
In the present work the ConA, a tetravalent, mannose/glucose specifi c, cell 
binding plant lectin [3] was used for the routine induction of infl ammatory ascites 
to test various compounds for inhibitory activity. The results indicate the contri-
bution of the kallikrein/kinin system to the mediation of the ConA induced as-
cites.
Materials and Methods
The chemicals were Sigma products, except the Kunitz-type soyabean 
trypsin inhibitor (Reanal). The agents were dissolved in physiological saline, the 
ConA always freshly. MK886 was fi rst dissolved with a drop of ethanol, then 
fi lled up with saline to the required volume.
Animals: Female, 24 g NMRI mice of SPF origin were kept in cages and 
had free access to commercial chow and water. – The experiments complied with 
the Hungarian Animal Welfare Act XXVIII/1998 and Edict 243/1998 (amended 
in 2012) and were approved by the Veterinary Offi ce of Somogy County 1126/001/
SOM/2005 and the local ethical committee.
Protocol: The animals were used in groups of fi ve or six, except men-
tioned. Both i.p. and s.c. injections were administered in 0.1 ml volume. Infl am-
matory ascites was induced by injecting ConA (25 mg/kg b.w.) intraperitoneally 
with or without inhibitor. One or 2.5 h later the animals were decapitated under 
ether anaesthesia, the abdomen was opened along the linea alba, and the ascitic 
fl uid was carefully collected with a pipette, always performed by the same per-
son. The volume was measured by pipetting the fl uid into another vessel and 
 expressed as % of body weight. Blood-stained samples were discarded.
Aprotinin (in the 2.5 h experiment), fetuin and icatibant were adminis-
tered mixed with the ConA inducer. Other inhibitors were injected s.c., 20 min 
before the induction. In the 2.5 h experiment half of the L-NAME dose was 
added before the induction by ConA and the other half 1 h later.
Statistics: Signifi cance of differences was calculated with ANOVA of the 
SPSS program.
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Results
I.p. injection of 0.1 ml of physiological saline was used as a negative con-
trol. Due to the absorption of the saline, this control produced very low perito-
neal fl uid volumes, which could not be exactly measured, and were not consid-
ered.
I.p. administered ConA (25 mg/kg b.w.) was used as positive control. Its 
repetition did not produce signifi cant differences. The same treatment was used 
routinely in the experiments with inhibitors. In the icatibant study another ConA 
charge with slightly lower activity was used.
In the 2.5 h experiment (Figure 1) fetuin (75 mg/kg b.w.), atropine methyl-
nitrate (0.4 mg/kg), L-NAME (N-nitro-L-arginine-methyl-esther. HCl, 30 mg/kg) 
and aprotinin (a trypsin and kallikrein inhibitor protein, 100 mg/kg) were tested 
Figure 1. Inhibition of ConA-induced ascites, 2.5 h experiment.
Collected ascitic fl uid in % of body weight. Mean±SD. Asteriscs indicate signifi cant differences 
as compared to the ConA control: *p<0.05; **p<0.01. See the text for the doses.
ConA = control without inhibitor (n = 5); Fet = fetuin (n = 5); Atr = atropine methylnitrate (n = 6); 
NAME = N-nitro-L-arginine-methyl-esther (n = 6); Apr = aprotinin (n = 4)
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Figure 2. Inhibition of ConA-induced ascites, 1 h experiment. See Fig. 1. for explanation.
ConA = control without inhibitor (n = 5); NAME = N-nitro-L-arginine-methyl-esther (n = 8); 
Apr = aprotinin (n = 6); KTI = Kunitz trypsin inhibitor (n = 5); 
BBI = Bowman-Birk trypsin-chymotrypsin inhibitor (n = 4); MK= MK886 (n = 8)
as inhibitors. Fetuin (p<0.05) and aprotinin (p<0.01) signifi cantly reduced the 
volume of the of ascitic fl uid. Other treatments did not reach the level of signifi -
cance.
In the 1 h experiment (Fig. 2) two treatments were repeated with similar 
results as before: aprotinin (100 mg/kg) was markedly inhibitory (p<0.01), and 
L-NAME (20 mg/kg) was ineffective. Three additional compounds exerted slight 
inhibitory effect (p<0.05), namely, the Kunitz (100 mg/kg) and Bowman-Birk 
(100 mg/kg) trypsin inhibitors of the soyabean, and a leukotriene synthesis in-
hibitor (MK886, 3 mg/kg).
In a third experiment (Fig. 3) icatibant acetate (HOE-140), a bradykinin 
receptor antagonist polypeptide was tested, and highly signifi cant (p<0.01) inhi-
bition of fl uid accumulation was observed at both 5 and 25 mg/kg b.w. dose level.
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Discussion
In an earlier study a wide range of macromolecules was screened for the 
ability to induce infl ammatory ascites [2], still before the major infl ux of leuko-
cytes [4]. In further studies ConA was chosen for routine induction of ascites to 
clarify the mechanism of the process. Histamine was excluded as mediator [5]. 
Figure 3. Inhibition of ConA-induced ascites with icatibant (HOE-140), 1 h experiment.
Control = ConA without inhibitor (n = 7); 5 mg/kg (n = 5) and 25 mg/kg icatibant (n = 6)
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Next we applied other potential inhibitors of ascites formation to obtain indi-
rect information about the mediators. In a preliminary screening thalidomide 
(NFκB inhibitor), captopril (ACE- and tissue metalloproteinase inhibitor) and 
ZM323881 (VEGF receptor antagonist) had no inhibitory effect (unpublished). 
In the present work conclusions were drawn only if the differences reached the 
1% confi dence level as compared to the positive control group (ConA alone).
In both the 2.5 h and 1 h experiments (Figs. 1 and 2) high aprotinin dose 
(100 mg/kg b.w.) was required for signifi cant (p<0.01) inhibition of ConA-in-
duced ascites. The bradykinin receptor antagonist icatibant was more effective 
than aprotinin and produced dose-dependent inhibition (p<0.01, Fig. 3). It is 
concluded that the kallikrein/kinin system contributed to the mediation of the 
 ConA-induced ascites via the B2 receptor. The role of the inducible B1 receptor 
can be excluded, because of the short duration of the present experiments. The 
fi ndings are in agreement with the ascites-inducing role of kallikrein in the ovar-
ian hyperstimulation syndrome [6].
In the present work complete inhibition of ConA-induced ascites could 
not be achieved, which indicates the involvement of additional mediators.
It is known that bradykinin produces vasodilatation by the activation of 
eNOS. However, the inhibition of NO synthesis by L-NAME (Figs. 1 and 2) did 
not affect the ConA-induced ascites. Permeability of subperitoneal capillaries 
may be controlled by Ca2+ infl ux, another effect of bradykinin [7].
The native, tetravalent ConA makes non-covalent cross-links between the 
glycosyl side-chains of cell surface glycoproteins resulting in their aggregation 
[8]. The monovalent succinyl-ConA is ineffective [2]. The distortion of mem-
brane structure may activate membrane prekallikrein [9] resulting in the re-
lease of kinins. Cellular mediation of the ConA-induced ascites is beyond the 
scope of the present paper.
In spite of being trypsin-like proteinases, kallikreins are not inhibited 
by the trypsin inhibitors of the soyabean. However, both Kunitz and Bowman-
Birk inhibitors exerted a small, but signifi cant (p<0.05) effect on the ConA- 
induced ascites (Fig. 2).
Parasympathic mediation was excluded, using atropine methylnitrate 
( Fig. 1), a molecular variant without central effect.
Fetuin is a mannose-containing, heavily glycosylated serum protein. When 
injected in threefold excess (by weight) of ConA, it exerted slight but signifi cant 
(p<0.05) inhibitory effect on the accumulation of peritoneal fl uid (Fig. 1). Al-
though the mannose residue directly reacts with the functional moiety of the 
ConA molecule, in vivo the lectins are transposed to the cell membrane receptors 
[2], which may explain the poor inhibitory effect of fetuin.
 ConA, ASCITES AND KALLIKREIN 137
Acta Microbiologica et Immunologica Hungarica 63, 2016
Confl ict of Interest
The authors declare that there is no confl ict of interests regarding the pub-
lication of this paper.
References
1. Tsilibary, E. C., Wissig, S. L.: Light and electron microscope observations of the lym-
phatic drainage units of the peritoneal cavity of rodents. Am J Anat 180, 197–207 (1987).
2. Baintner, K.: Infl ammatory ascites formation induced by macromolecules in mice and 
rats. Am J Physiol Regul Integr Comp Physiol 296, R218–R223 (2009).
3. Van Damme, E. J. M., Peumans, W. J., Pusztai, A., Bardocz, S.: (1997): Handbook of Plant 
Lectins: Properties and Biomedical Applications. – Chapter: Canavalia ensiformis, p. 
141. Wiley, New York.
4. Baintner, K., Bodnár, Z., Kiss, P. L. Kiss, A., Lukáts, A.: Effect of intraperitoneally ad-
ministered plant lectins on leukocyte diapedesis and visceral organ weight in rats and 
mice. Pathol Oncol Res 13, 139–143 (2007).
5. Baintner, K.: Modulation of ConA-induced infl ammatory ascites by histamine – short 
communication. Acta Microbiol Immunol Hung 62, 87–91 (2015).
6. Kobayashi, H., Okada, Y., Asahina, T., Gotoh, J., Terao, T.: The kallikrein-kinin system, 
but not VEGF, plays a role in the increased vascular permeability associated with OHS. 
J Molec Endocrinol 20, 363–374 (1998).
7. Tiruppathi, C., Ahmmed, G. U., Vogel, S. M., Malik, A. B.: Ca2+ signaling, TRP channels, 
and endothelial permeability. Microcirculation 13, 693–708 (2006).
8. Shiba, T., Tobe, K., Koshio, O., Yamamoto, R., Shibasaki, Y., Matsumoto, N., Toyoshima, 
S., Osawa, T., Akanuma, Y., Takaku, F.: Concanavalin A-induced receptor aggregation 
stimulates the tyrosine kinase activity of the insulin receptor in intact cells. Biochem J 
267, 787–794 (1990).
9. Erez, E., Fass, D., Bibi, E.: How intramembrane proteases bury hydrolytic reactions in 
the membrane. Nature (Insight) 459, 371–378 (2009).
